SK pharmteco is the single market-facing team comprised of SK biotek and AMPAC Fine Chemicals.  

This new force within the API CDMO space provides customers with world-class state-of-the-art facilities and technology with the highest-quality services.

We specialize in commercial and clinical production of APIs and Advanced Intermediates.  We have extensive expertise in Highly Potent APIs, Controlled Substances, Energetic Chemistry, Chromatographic Separations, Particle Engineering and Continuous Processing.

Our scientists and engineers are leaders in continuous manufacturing methodologies, having successfully developed processes from kilograms through metric tons. We have implemented this successfully in our many years of developing processes that utilize energetic reactions.  We are also leaders in Simulated Moving Bed (SMB) chromatography and offer this powerful technology from lab through pilot to large commercial scale.  

Our offering also includes process research and development, analytical method development, scale-up and optimization, validation and stability within in our global network.  We also provide the same analytical service as a stand-alone business at our Analytical Services facility in California.

We are leaders in operational excellence and continuous improvement and boast exceptional technical capabilities. The global presence of our highly skilled and experienced team offers total support from development through to commercial production including seamless project transfer and management. 

All our plants have been approved by global regulatory agencies including the FDA, EMEA, PDMA and Korean MFDS.  We provide PAI and full regulatory support as well as complete confidentiality.  We have a strong record of environmental, health and safety performance.

At SK pharmteco, we believe in a ‘One Team’ approach, regardless of geographical location, ensuring open lines of communication and multi-disciplinary collaboration.  Taking a ‘sense of ownership together with our customers’ viewpoint’ is a proud facet of SK pharmteco’s culture.  With ~1000 m³ across six cGMP manufacturing and development sites in the USA, Korea and Ireland, gives our customers flexibility and choice.  Whether it is Continuous Manufacturing or Batch, we have a number of locations and capabilities to support all your API and Intermediate needs across the full lifecycle.  As an SK customer, we will stand over your product as if it were our own.  We have been producing many of the world’s most recognized drugs for over 75 years.  

If you are looking for a CDMO that combines the above with a stellar inspection record and commitment to  “Safety First, Quality always”, then give us a call!